Bratton Capital Management, L.P.

Bratton Capital Management, L.P. latest Q4_2020 13F filings reported $61,543,000 in market value on this 2021-02-12 report date . The portfolio quarterly return is -14.41%. This fund has 1 securities concentrations of 100% weights.

Bratton Capital Management, L.P. largest holding is Aquestive Therapeutics Inc. with weight of 100.00% and $61,543,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-122020-12-31Q4_202013F-HR1$61,543,000-14.41%
2020-11-132020-09-30Q3_202013F-HR2$71,901,0007.73%
2020-08-142020-06-30Q2_202013F-HR2$66,739,00059.36%
2020-05-132020-03-31Q1_202013F-HR2$41,879,000-49.88%
2020-02-122019-12-31Q4_201913F-HR2$83,551,00063.25%
2019-11-132019-09-30Q3_201913F-HR2$51,180,000-24.84%
2019-08-132019-06-30Q2_201913F-HR2$68,098,000-32.98%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
AQUESTIVE THERAPEUTICS INCAQSTINCR$61,5430.10%100.00%$5.350.00%11,503,294
DENALI THERAPEUTICS INCDNLISOLD$00.00%-100.00%$0.000.00%0